{
  "DOI": "10.1007/s10689-020-00163-8",
  "ISSN": [
    "1389-9600",
    "1573-7292"
  ],
  "URL": "http://dx.doi.org/10.1007/s10689-020-00163-8",
  "alternative-id": [
    "163"
  ],
  "assertion": [
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "First Online",
      "name": "first_online",
      "order": 1,
      "value": "11 February 2020"
    },
    {
      "group": {
        "label": "Compliance with ethical standards",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 1
    },
    {
      "group": {
        "label": "Conflict of interest",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 2,
      "value": "The authors declare that they have no conflict of interest."
    },
    {
      "group": {
        "label": "Ethical approval",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 3,
      "value": "This study was approved by the Singhealth Centralized Institutional Review Board (IRB 2010/426/B) with signed inform consent from participants."
    }
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Toh",
      "given": "Ming Ren",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Low",
      "given": "Chen Ee",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Chong",
      "given": "Siao Ting",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Chan",
      "given": "Sock Hoai",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Ishak",
      "given": "Nur Diana Binte",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Courtney",
      "given": "Eliza",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Kolinjivadi",
      "given": "Arun Mouli",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Rodrigue",
      "given": "Amélie",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Masson",
      "given": "Jean-Yves",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Ngeow",
      "given": "Joanne",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "Familial Cancer"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": [
      "link.springer.com"
    ]
  },
  "created": {
    "date-parts": [
      [
        2020,
        2,
        11
      ]
    ],
    "date-time": "2020-02-11T06:16:20Z",
    "timestamp": 1581401780000
  },
  "deposited": {
    "date-parts": [
      [
        2021,
        2,
        10
      ]
    ],
    "date-time": "2021-02-10T07:27:55Z",
    "timestamp": 1612942075000
  },
  "funder": [
    {
      "DOI": "10.13039/501100001349",
      "award": [
        "NMRC/CSA-INV/0017/2017"
      ],
      "doi-asserted-by": "crossref",
      "name": "National Medical Research Council"
    }
  ],
  "indexed": {
    "date-parts": [
      [
        2022,
        7,
        7
      ]
    ],
    "date-time": "2022-07-07T08:10:07Z",
    "timestamp": 1657181407826
  },
  "is-referenced-by-count": 3,
  "issn-type": [
    {
      "type": "print",
      "value": "1389-9600"
    },
    {
      "type": "electronic",
      "value": "1573-7292"
    }
  ],
  "issue": "2",
  "issued": {
    "date-parts": [
      [
        2020,
        2,
        11
      ]
    ]
  },
  "journal-issue": {
    "issue": "2",
    "published-print": {
      "date-parts": [
        [
          2020,
          4
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "http://www.springer.com/tdm",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2020,
            2,
            11
          ]
        ],
        "date-time": "2020-02-11T00:00:00Z",
        "timestamp": 1581379200000
      }
    },
    {
      "URL": "http://www.springer.com/tdm",
      "content-version": "vor",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2020,
            2,
            11
          ]
        ],
        "date-time": "2020-02-11T00:00:00Z",
        "timestamp": 1581379200000
      }
    }
  ],
  "link": [
    {
      "URL": "http://link.springer.com/content/pdf/10.1007/s10689-020-00163-8.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/article/10.1007/s10689-020-00163-8/fulltext.html",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/content/pdf/10.1007/s10689-020-00163-8.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "page": "123-131",
  "prefix": "10.1007",
  "published": {
    "date-parts": [
      [
        2020,
        2,
        11
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2020,
        2,
        11
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2020,
        4
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.1093/nar/gks807",
      "author": "R Buisson",
      "doi-asserted-by": "publisher",
      "first-page": "10312",
      "issue": "20",
      "journal-title": "Nucl Acids Res",
      "key": "163_CR1",
      "unstructured": "Buisson R, Masson J-Y (2012) PALB2 self-interaction controls homologous recombination. Nucl Acids Res 40(20):10312–10323",
      "volume": "40",
      "year": "2012"
    },
    {
      "DOI": "10.1038/onc.2013.421",
      "author": "J-Y Park",
      "doi-asserted-by": "publisher",
      "first-page": "4803",
      "issue": "40",
      "journal-title": "Oncogene",
      "key": "163_CR2",
      "unstructured": "Park J-Y, Singh TR, Nassar N, Zhang F, Freund M, Hanenberg H, Meetei AR, Andreassen PR (2014) Breast cancer-associated missense mutants of the PALB2 WD40 domain, which directly binds RAD51C, RAD51 and BRCA2, disrupt DNA repair. Oncogene 33(40):4803–4812",
      "volume": "33",
      "year": "2014"
    },
    {
      "DOI": "10.1016/j.tibs.2018.10.008",
      "author": "M Ducy",
      "doi-asserted-by": "publisher",
      "first-page": "226",
      "issue": "3",
      "journal-title": "Trends Biochem Sci",
      "key": "163_CR3",
      "unstructured": "Ducy M, Sesma-Sanz L, Guitton-Sert L, Lashgari A, Gao Y, Brahiti N, Rodrigue A, Margaillan G, Caron M-C, Côté J (2019) The tumor suppressor PALB2: inside out. Trends Biochem Sci 44(3):226–240",
      "volume": "44",
      "year": "2019"
    },
    {
      "DOI": "10.1038/ng1942",
      "author": "B Xia",
      "doi-asserted-by": "publisher",
      "first-page": "159",
      "issue": "2",
      "journal-title": "Nat Genet",
      "key": "163_CR4",
      "unstructured": "Xia B, Dorsman JC, Ameziane N, de Vries Y, Rooimans MA, Sheng Q, Pals G, Errami A, Gluckman E, Llera J (2007) Fanconi anemia is associated with a defect in the BRCA2 partner PALB2. Nat Genet 39(2):159–161",
      "volume": "39",
      "year": "2007"
    },
    {
      "author": "X Yang",
      "first-page": "56",
      "journal-title": "J Clin Oncol",
      "key": "163_CR5",
      "unstructured": "Yang X, Leslie G, Doroszuk A, Schneider S, Allen J, Decker B, Dunning AM, Redman J, Scarth J, Plaskocinska I, Luccarini C, Shah M, Pooley K, Dorling L, Lee A, Adank MA, Adlard J, Aittomäki K, Andrulis IL, Ang P, Barwell J, Bernstein JL, Bobolis K, Borg Å, Blomqvist C, Claes KBM, Concannon P, Cuggia A, Culver JO, Damiola F, de Pauw A, Diez O, Dolinsky JS, Domchek SM, Engel C, Evans DG, Fostira F, Garber J, Golmard L, Goode EL, Gruber SB, Hahnen E, Hake C, Heikkinen T, Hurley JE, Janavicius R, Kleibl Z, Kleiblova P, Konstantopoulou I, Kvist A, Laduca H, Lee ASG, Lesueur F, Maher ER, Mannermaa A, Manoukian S, McFarland R, McKinnon W, Meindl A, Metcalfe K, Mohd Taib NA, Moilanen J, Nathanson KL, Neuhausen S, Ng PS, Nguyen-Dumont T, Nielsen SM, Obermair F, Offit K, Olopade OI, Ottini L, Penkert J, Pylkäs K, Radice P, Ramus SJ, Rudaitis V, Side L, Silva-Smith R, Silvestri V, Skytte A-B, Slavin T, Soukupova J, Tondini C, Trainer AH, Unzeitig G, Usha L, van Overeem HT, Whitworth J, Wood M, Yip CH, Yoon S-Y, Yussuf A, Zogopoulos G, Goldgar D, Hopper JL, Chenevix-Trench G, Pharoah P, George SHL, Balmaña J, Houdayer C, James P, El-Haffaf Z, Ehrencrona H, Janatova M, Peterlongo P, Nevanlinna H, Schmutzler R, Teo S-H, Robson M, Pal T, Couch F, Weitzel JN, Elliott A, Southey M, Winqvist R, Easton DF, Foulkes WD, Antoniou AC, Tischkowitz M (2019) Cancer risks associated with germline PALB2 pathogenic variants: an international study of 524 families. J Clin Oncol 12:56–89",
      "volume": "12",
      "year": "2019"
    },
    {
      "DOI": "10.1001/jama.2017.7112",
      "author": "KB Kuchenbaecker",
      "doi-asserted-by": "publisher",
      "first-page": "2402",
      "issue": "23",
      "journal-title": "Jama",
      "key": "163_CR6",
      "unstructured": "Kuchenbaecker KB, Hopper JL, Barnes DR, Phillips K-A, Mooij TM, Roos-Blom M-J, Jervis S, Van Leeuwen FE, Milne RL, Andrieu N (2017) Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers. Jama 317(23):2402–2416",
      "volume": "317",
      "year": "2017"
    },
    {
      "DOI": "10.1016/S1470-2045(15)70142-7",
      "author": "C Cybulski",
      "doi-asserted-by": "publisher",
      "first-page": "638",
      "issue": "6",
      "journal-title": "Lancet Oncol",
      "key": "163_CR7",
      "unstructured": "Cybulski C, Kluźniak W, Huzarski T, Wokołorczyk D, Kashyap A, Jakubowska A, Szwiec M, Byrski T, Dębniak T, Górski B (2015) Clinical outcomes in women with breast cancer and a PALB2 mutation: a prospective cohort analysis. Lancet Oncol 16(6):638–644",
      "volume": "16",
      "year": "2015"
    },
    {
      "DOI": "10.1001/jamaoncol.2015.2690",
      "author": "A Desmond",
      "doi-asserted-by": "publisher",
      "first-page": "943",
      "issue": "7",
      "journal-title": "JAMA Oncol",
      "key": "163_CR8",
      "unstructured": "Desmond A, Kurian AW, Gabree M, Mills MA, Anderson MJ, Kobayashi Y, Horick N, Yang S, Shannon KM, Tung N (2015) Clinical actionability of multigene panel testing for hereditary breast and ovarian cancer risk assessment. JAMA Oncol 1(7):943–951",
      "volume": "1",
      "year": "2015"
    },
    {
      "DOI": "10.1038/gim.2015.30",
      "author": "S Richards",
      "doi-asserted-by": "publisher",
      "first-page": "405",
      "issue": "5",
      "journal-title": "Genet Med",
      "key": "163_CR9",
      "unstructured": "Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody W, Hegde M, Lyon E, Spector E (2015) ACMG Laboratory Quality Assurance Committee Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 17(5):405–424",
      "volume": "17",
      "year": "2015"
    },
    {
      "DOI": "10.3389/fonc.2018.00480",
      "author": "L Caleca",
      "doi-asserted-by": "publisher",
      "first-page": "480",
      "journal-title": "Front Oncol",
      "key": "163_CR10",
      "unstructured": "Caleca L, Catucci I, Figlioli G, De Cecco L, Pesaran T, Ward M, Volorio S, Falanga A, Marchetti M, Iascone M (2018) Missense variants detected in breast cancer families preventing BRCA2-PALB2 protein interaction. Front Oncol 8:480",
      "volume": "8",
      "year": "2018"
    },
    {
      "DOI": "10.1371/journal.pone.0073638",
      "author": "SY Phuah",
      "doi-asserted-by": "publisher",
      "first-page": "e73638",
      "issue": "8",
      "journal-title": "PLoS ONE",
      "key": "163_CR11",
      "unstructured": "Phuah SY, Lee SY, Kang P, Kang IN, Yoon S-Y, Thong MK, Hartman M, Sng J-H, Yip CH, Taib NAM, Teo S-H (2013) Prevalence of PALB2 mutations in breast cancer patients in multi-ethnic Asian population in Malaysia and Singapore. PLoS ONE 8(8):e73638",
      "volume": "8",
      "year": "2013"
    },
    {
      "DOI": "10.1016/j.gofs.2018.08.006",
      "author": "A Piffer",
      "doi-asserted-by": "publisher",
      "first-page": "701",
      "issue": "10",
      "journal-title": "Gynécologie Obstétrique Fertilité Sénologie",
      "key": "163_CR12",
      "unstructured": "Piffer A, Luporsi E, Mathelin C (2018) PALB2, gène majeur de susceptibilité au cancer du sein. Gynécologie Obstétrique Fertilité Sénologie 46(10):701–705",
      "volume": "46",
      "year": "2018"
    },
    {
      "key": "163_CR13",
      "unstructured": "NCBI ClinVar. https://www.ncbi.nlm.nih.gov/clinvar/?term=palb2%5Bgene%5D. Last Accessed Dec 2019"
    },
    {
      "DOI": "10.1073/pnas.0701724104",
      "author": "M Tischkowitz",
      "doi-asserted-by": "publisher",
      "first-page": "6788",
      "issue": "16",
      "journal-title": "Proc Natl Acad Sci USA",
      "key": "163_CR14",
      "unstructured": "Tischkowitz M, Xia B, Sabbaghian N, Reis-Filho JS, Hamel N, Li G, van Beers EH, Li L, Khalil T, Quenneville LA (2007) Analysis of PALB2/FANCN-associated breast cancer families. Proc Natl Acad Sci USA 104(16):6788–6793",
      "volume": "104",
      "year": "2007"
    },
    {
      "author": "H Hanenberg",
      "first-page": "484",
      "issue": "12",
      "journal-title": "Atlas Genet Cytogenet Oncol Haematol",
      "key": "163_CR15",
      "unstructured": "Hanenberg H, Andreassen PR (2018) PALB2 (partner and localizer of BRCA2). Atlas Genet Cytogenet Oncol Haematol 22(12):484–490",
      "volume": "22",
      "year": "2018"
    },
    {
      "DOI": "10.1002/ijc.28361",
      "author": "MW Wong-Brown",
      "doi-asserted-by": "publisher",
      "first-page": "301",
      "issue": "2",
      "journal-title": "Int J Cancer",
      "key": "163_CR16",
      "unstructured": "Wong-Brown MW, Avery‐Kiejda KA, Bowden NA, Scott RJ (2014) Low prevalence of germline PALB2 mutations in Australian triple‐negative breast cancer. Int J Cancer 134(2):301–305",
      "volume": "134",
      "year": "2014"
    },
    {
      "DOI": "10.1056/NEJMoa1400382",
      "author": "AC Antoniou",
      "doi-asserted-by": "publisher",
      "first-page": "497",
      "issue": "6",
      "journal-title": "N Engl J Med",
      "key": "163_CR17",
      "unstructured": "Antoniou AC, Casadei S, Heikkinen T, Barrowdale D, Pylkäs K, Roberts J, Lee A, Subramanian D, De Leeneer K, Fostira F, Tomiak E, Neuhausen SL, Teo ZL, Khan S, Aittomäki K, Moilanen JS, Turnbull C, Seal S, Mannermaa A, Kallioniemi A, Lindeman GJ, Buys SS, Andrulis IL, Radice P, Tondini C, Manoukian S, Toland AE, Miron P, Weitzel JN, Domchek SM, Poppe B, Claes KBM, Yannoukakos D, Concannon P, Bernstein JL, James PA, Easton DF, Goldgar DE, Hopper JL, Rahman N, Peterlongo P, Nevanlinna H, King M-C, Couch FJ, Southey MC, Winqvist R, Foulkes WD, Tischkowitz M (2014) Breast-cancer risk in families with mutations in PALB2. N Engl J Med 371(6):497–506",
      "volume": "371",
      "year": "2014"
    },
    {
      "DOI": "10.1158/1078-0432.CCR-08-3128",
      "author": "T Heikkinen",
      "doi-asserted-by": "publisher",
      "first-page": "3214",
      "issue": "9",
      "journal-title": "Clin Cancer Res",
      "key": "163_CR18",
      "unstructured": "Heikkinen T, Kärkkäinen H, Aaltonen K, Milne RL, Heikkilä P, Aittomäki K, Blomqvist C, Nevanlinna H (2009) The breast cancer susceptibility mutation PALB2 1592delT is associated with an aggressive tumor phenotype. Clin Cancer Res 15(9):3214–3222",
      "volume": "15",
      "year": "2009"
    },
    {
      "DOI": "10.1093/nar/gkx011",
      "author": "J Pauty",
      "doi-asserted-by": "publisher",
      "first-page": "2644",
      "issue": "5",
      "journal-title": "Nucl Acids Res",
      "key": "163_CR19",
      "unstructured": "Pauty J, Couturier AM, Rodrigue A, Caron M-C, Coulombe Y, Dellaire G, Masson J-Y (2017) Cancer-causing mutations in the tumor suppressor PALB2 reveal a novel cancer mechanism using a hidden nuclear export signal in the WD40 repeat motif. Nucl Acids Res 45(5):2644–2657",
      "volume": "45",
      "year": "2017"
    },
    {
      "DOI": "10.1093/nar/gkz780",
      "author": "GM Amélie Rodrigue",
      "doi-asserted-by": "publisher",
      "first-page": "10662",
      "issue": "20",
      "journal-title": "Nucleic Acids Res",
      "key": "163_CR20",
      "unstructured": "Amélie Rodrigue GM, Gomes TT, Coulombe Y, Ducy M, da Costa e Silva Carvalho S, De-Gregoriis G, de Souza LM, Dellaire G, da Silva Junior WA, Monteiro A, Carvalho M, Simard J, Masson J-Y (2019) A global functional analysis of missense mutations reveals two major hotspots in the PALB2 tumor suppressor. Nucleic Acids Res 47(20):10662–10677",
      "volume": "47",
      "year": "2019"
    },
    {
      "DOI": "10.1373/clinchem.2004.036053",
      "author": "D Tchernitchko",
      "doi-asserted-by": "publisher",
      "first-page": "1974",
      "issue": "11",
      "journal-title": "Clin Chem",
      "key": "163_CR21",
      "unstructured": "Tchernitchko D, Goossens M, Wajcman H (2004) In silico prediction of the deleterious effect of a mutation: proceed with caution in clinical genetics. Clin Chem 50(11):1974–1978",
      "volume": "50",
      "year": "2004"
    },
    {
      "DOI": "10.1038/embor.2011.243",
      "author": "JY Bleuyard",
      "doi-asserted-by": "publisher",
      "first-page": "135",
      "issue": "2",
      "journal-title": "EMBO Rep",
      "key": "163_CR22",
      "unstructured": "Bleuyard JY, Buisson R, Masson JY, Esashi F (2012) ChAM, a novel motif that mediates PALB2 intrinsic chromatin binding and facilitates DNA repair. EMBO Rep 13(2):135–141",
      "volume": "13",
      "year": "2012"
    },
    {
      "DOI": "10.1038/nature05609",
      "author": "H Erkko",
      "doi-asserted-by": "publisher",
      "first-page": "316",
      "journal-title": "Nature",
      "key": "163_CR23",
      "unstructured": "Erkko H, Xia B, Nikkilä J, Schleutker J, Syrjäkoski K, Mannermaa A, Kallioniemi A, Pylkäs K, Karppinen S-M, Rapakko K, Miron A, Sheng Q, Li G, Mattila H, Bell DW, Haber DA, Grip M, Reiman M, Jukkola-Vuorinen A, Mustonen A, Kere J, Aaltonen LA, Kosma V-M, Kataja V, Soini Y, Drapkin RI, Livingston DM, Winqvist R (2007) A recurrent mutation in PALB2 in Finnish cancer families. Nature 446:316–319",
      "volume": "446",
      "year": "2007"
    },
    {
      "DOI": "10.1038/nature13127",
      "author": "D MacArthur",
      "doi-asserted-by": "publisher",
      "first-page": "469",
      "issue": "7497",
      "journal-title": "Nature",
      "key": "163_CR24",
      "unstructured": "MacArthur D, Manolio T, Dimmock D, Rehm H, Shendure J, Abecasis G, Adams D, Altman R, Antonarakis S, Ashley E (2014) Guidelines for investigating causality of sequence variants in human disease. Nature 508(7497):469–476",
      "volume": "508",
      "year": "2014"
    },
    {
      "DOI": "10.1186/s13073-016-0391-z",
      "author": "RY Patel",
      "doi-asserted-by": "publisher",
      "first-page": "3",
      "issue": "1",
      "journal-title": "Genome Med",
      "key": "163_CR25",
      "unstructured": "Patel RY, Shah N, Jackson AR, Ghosh R, Pawliczek P, Paithankar S, Baker A, Riehle K, Chen H, Milosavljevic S, Bizon C, Rynearson S, Nelson T, Jarvik GP, Rehm HL, Harrison SM, Azzariti D, Powell B, Babb L, Plon SE, Milosavljevic A, on behalf of the ClinGen R (2017) ClinGen pathogenicity calculator: a configurable system for assessing pathogenicity of genetic variants. Genome Med 9(1):3",
      "volume": "9",
      "year": "2017"
    },
    {
      "DOI": "10.1101/531210",
      "author": "KJ Karczewski",
      "doi-asserted-by": "publisher",
      "journal-title": "bioRxiv",
      "key": "163_CR26",
      "unstructured": "Karczewski KJ, Francioli LC, Tiao G, Cummings BB, Alföldi J, Wang Q, Collins RL, Laricchia KM, Ganna A, Birnbaum DP, Gauthier LD, Brand H, Solomonson M, Watts NA, Rhodes D, Singer-Berk M, England EM, Seaby EG, Kosmicki JA, Walters RK, Tashman K, Farjoun Y, Banks E, Poterba T, Wang A, Seed C, Whiffin N, Chong JX, Samocha KE, Pierce-Hoffman E, Zappala Z, O’Donnell-Luria AH, Minikel EV, Weisburd B, Lek M, Ware JS, Vittal C, Armean IM, Bergelson L, Cibulskis K, Connolly KM, Covarrubias M, Donnelly S, Ferriera S, Gabriel S, Gentry J, Gupta N, Jeandet T, Kaplan D, Llanwarne C, Munshi R, Novod S, Petrillo N, Roazen D, Ruano-Rubio V, Saltzman A, Schleicher M, Soto J, Tibbetts K, Tolonen C, Wade G, Talkowski ME, Neale BM, Daly MJ, MacArthur DG (2019) Variation across 141,456 human exomes and genomes reveals the spectrum of loss-of-function intolerance across human protein-coding genes. bioRxiv.https://doi.org/10.1101/531210",
      "year": "2019"
    },
    {
      "DOI": "10.1038/nmeth0410-248",
      "author": "IA Adzhubei",
      "doi-asserted-by": "publisher",
      "first-page": "248",
      "issue": "4",
      "journal-title": "Nat Methods",
      "key": "163_CR27",
      "unstructured": "Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, Bork P, Kondrashov AS, Sunyaev SR (2010) A method and server for predicting damaging missense mutations. Nat Methods 7(4):248–249",
      "volume": "7",
      "year": "2010"
    },
    {
      "DOI": "10.1038/nprot.2009.86",
      "author": "P Kumar",
      "doi-asserted-by": "publisher",
      "first-page": "1073",
      "issue": "7",
      "journal-title": "Nat Protoc",
      "key": "163_CR28",
      "unstructured": "Kumar P, Henikoff S, Ng PC (2009) Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat Protoc 4(7):1073–1081",
      "volume": "4",
      "year": "2009"
    },
    {
      "DOI": "10.1136/jmg.2005.033878",
      "author": "SV Tavtigian",
      "doi-asserted-by": "publisher",
      "first-page": "295",
      "issue": "4",
      "journal-title": "J Med Genet",
      "key": "163_CR29",
      "unstructured": "Tavtigian SV, Deffenbaugh AM, Yin L, Judkins T, Scholl T, Samollow PB, de Silva D, Zharkikh A, Thomas A (2006) Comprehensive statistical study of 452 BRCA1 missense substitutions with classification of eight recurrent substitutions as neutral. J Med Genet 43(4):295–305",
      "volume": "43",
      "year": "2006"
    },
    {
      "DOI": "10.1093/jncics/pky054",
      "author": "MR Toh",
      "doi-asserted-by": "publisher",
      "first-page": "054",
      "issue": "4",
      "journal-title": "JNCI Cancer Spectrum",
      "key": "163_CR30",
      "unstructured": "Toh MR, Chiang JB, Chong ST, Chan SH, Ishak NDB, Courtney E, Lee WH, Syed Abdillah Al SMFB, Carson Allen J, Jr Lim KH (2018) Germline pathogenic variants in homologous recombination and DNA repair genes in an Asian cohort of young-onset colorectal cancer. JNCI Cancer Spectrum 2(4):054",
      "volume": "2",
      "year": "2018"
    },
    {
      "DOI": "10.1186/1756-0500-3-294",
      "author": "K Suzuki",
      "doi-asserted-by": "publisher",
      "first-page": "294",
      "journal-title": "BMC Res Notes",
      "key": "163_CR31",
      "unstructured": "Suzuki K, Bose P, Leong-Quong RY, Fujita DJ, Riabowol K (2010) REAP: a two minute cell fractionation method. BMC Res Notes 3:294",
      "volume": "3",
      "year": "2010"
    },
    {
      "DOI": "10.1038/nmeth.2089",
      "author": "CA Schneider",
      "doi-asserted-by": "publisher",
      "first-page": "671",
      "journal-title": "Nat Methods",
      "key": "163_CR32",
      "unstructured": "Schneider CA, Rasband WS, Eliceiri KW (2012) NIH Image to ImageJ: 25 years of image analysis. Nat Methods 9:671",
      "volume": "9",
      "year": "2012"
    }
  ],
  "reference-count": 32,
  "references-count": 32,
  "resource": {
    "primary": {
      "URL": "http://link.springer.com/10.1007/s10689-020-00163-8"
    }
  },
  "score": 0,
  "short-container-title": [
    "Familial Cancer"
  ],
  "source": "Crossref",
  "title": [
    "Missense PALB2 germline variant disrupts nuclear localization of PALB2 in a patient with breast cancer"
  ],
  "type": "journal-article",
  "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy",
  "volume": "19"
}